Rapid membrane recycling in nerve terminals is required to maintain rapid synaptic transmission. Following the fusion of synaptic vesicles with synaptic plasma membranes, recycling can occur via clathrincoated vesicles (CCVs) [1-3]. The fate of these vesicles is uncertain: they could simply uncoat and acquire other proteins from the cytosol to regenerate synaptic vesicles or they may fuse with endosomal structures from which synaptic vesicles could then bud. We have purified both CCVs and synaptic vesicles from rat brain, and measured the ability of these vesicle fractions to take up the excitatory neurotransmitter glutamic acid. We found that the normalized levels of glutamate uptake by the two types of vesicle were very similar. For each vesicle fraction, uptake required ATP and Cl -and could be fully inhibited by the specific vacuolar proton pump (v-ATPase) inhibitor concanamycin. We suggest that this ability to refill vesicles with neurotransmitter at the earliest intermediate on the recycling pathwaythe CCV -may allow uncoated vesicles to immediately enter the releasable pool without sacrificing the quantal nature of neurotransmitter release.
Nerve terminal CCVs are a distinct population of vesicles which incorporate both the plasma-membrane-associated AP2 adaptor protein and several markers of synaptic vesicles [2, 4] . It has been shown that CCVs prepared from rat cortex nerve terminals contain, at the same stoichiometries as purified synaptic-vesicle fractions, integral proteins that are widely used marker proteins for synaptic vesicles [2] . These proteins include the v-SNARE synaptobrevin, the Ca 2+ -sensor synaptotagmin, subunits of v-ATPase, and an abundant protein of unknown function, synaptophysin. These observations have been important in establishing the recycling pathway of CCVs as a significant route of synaptic-vesicle protein recycling. They are also consistent with a minimal model for the recycling pathway, in which uncoating of the first intermediate vesicle -the CCV -can essentially generate a synaptic vesicle without the necessity for passage through an endosomal intermediate.
We have used established methods to prepare fractions of synaptic vesicles [5] and CCVs [2] , and compared the ability of these fractions to take up glutamate, the major neurotransmitter of the central nervous system. In order to adjust for the large contributions of coat proteins to the content of the CCV fraction, we have normalized the glutamate uptake to the synaptophysin content of each fraction (Fig. 1) . Synaptophysin has been shown to localize specifically to the vesicles of the synaptic terminals in rat brain [6] . Electron-microscopic observation of the CCV preparations confirmed that over 90% of observable structures were coated, whereas the synaptic-vesicle preparation contained no coated structures and predominantly comprised small vesicles (Fig. 2) . Negatively stained preparations of synaptic vesicles and of stripped CCVs were efficiently labelled with an anti-synaptophysin antibody coupled to protein A-colloidal gold (data not shown). The major contaminant of these fractions is known to be myelinated membrane, which does not contain synaptophysin or take up glutamate by a mechanism dependent on v-ATPase.
The measured glutamate uptake we obtained was similar for each of the three purified vesicle fractions (Fig. 3) . We obtained similar results with CCVs prepared both from whole brain and from synaptosomes, consistent with the observation of Maycox et al. [2] that the stoichiometries of vesicle markers are unchanged between these preparations. For each of the three vesicle fractions, glutamate uptake was inhibited by the absence of ATP and Cl - (Fig.  3) . For the synaptic-vesicle fraction, our measured levels of uptake (in pmol g -1 ) are comparable to values published previously [7, 8] . Loss of coat protein from the CCVs was not observed during the incubation (data not shown).
The driving force for uptake into synaptic vesicles is provided by the vesicle membrane potential (∆) generated by the v-ATPase [8] . We have used a specific inhibitor of this pump, concanamycin, to show that uptake is completely dependent on v-ATPase activity for both CCVs and synaptic vesicles (Fig. 3) . The presence of an active vATPase may be a unique feature of endocytic CCVs derived from nerve terminals, as an endocytic CCV fraction derived from hepatocytes was found to be incapable of acidifying [9] . The v-ATPase is a multisubunit enzyme which may be regulated differentially according to its subcellular location. Although it has previously been shown to be present in CCVs derived from nerve terminals, to our knowledge, this is the first direct demonstration of its actual activity in this fraction.
Membrane recycling at the nerve terminal is fast relative to the rates observed in nonpolarized cells. Capacitance measurements on retinal bipolar cells of goldfish have revealed two time constants for membrane retrieval, depending on the duration of depolarization: 1-2 seconds following a brief depolarization, and 20-30 seconds following prolonged stimulation [10] . This indicates that there may be two separate mechanisms for membrane retrieval, with the fast phase corresponding to a 'kiss-and-run' model originally proposed by Ceccarelli et al. [11] in which, after fusion of the synaptic vesicle with the plasma membrane, the fusion pore never dilates but rather reseals, causing the synaptic vesicle to pinch off. The slower retrieval mechanism may correspond to recycling by the CCV pathway following full collapse of the synaptic vesicle into the plasma membrane, which has been observed in a number of morphological studies of synaptic-vesicle recycling [1, 3] , reviewed by De Camilli and Takei [12] . The relative importance of these two pathways in synaptic-vesicle recycling is presently controversial. Measurements of the time constants for retrieval of exocytosed membrane in rat hippocampal neurons and at the frog neuromuscular junction have yielded the values 20-40 and 60 seconds, respectively [13, 14] , consistent with recycling via CCVs.
The fate of CCVs after internalization is unclear. It was originally proposed that these vesicles coalesce, or fuse with existing endosomal structures, to form internal cisternae from which synaptic vesicles then bud [1] . This notion has been supported by studies of a neuroendocrine cell line, PC12, for which material to be incorporated into small synaptic-like vesicles is believed to pass through an early endosomal intermediate [15] [16] [17] . Recent morphological studies on isolated nerve terminals have suggested, however, that the observed cisternae correspond to large chunks of plasma membrane that have pinched off or that, in some cases, even remain contiguous with the plasma membrane [3] . Budding of CCVs from these cisternae was also elegantly demonstrated [3] ; the study did not completely rule out obligatory passage of material recycling via CCVs through an endosomal intermediate, but it has provided an alternative explanation for the key observation underpinning this idea. It now seems most likely that uncoating of CCVs generates synaptic vesicles without passage through a further compartment. According to this model, certain cytosolic proteins, for example rab3A, may have to associate with the vesicle after uncoating to confer exocytic properties [18] .
Regenerated synaptic vesicles do not go to the back of the queue for subsequent exocytosis, but rather reincorporate randomly into the releasable pool [19] . The time constant for reincorporation of retrieved vesicles into the releasable pool (the repriming time) has been measured as 30-60 seconds and 15-30 seconds in rat hippocampal neurons and at the frog neuromuscular junction, respectively [13, 14] . In order to ensure quantal release of (a) Enrichment of synaptophysin during the purification of vesicle fractions. CCVs were purified either from homogenate of whole brain (WB CCV) or from synaptosomes (nerve terminals, NT CCV) isolated from homogenate in a series of steps to give, consecutively, light membranes (LM), supernatant produced following Ficoll density gradient centrifugation (PFS), and a supernatant fraction enriched in clathrincoated structures (EF), which was then pelleted through a D 2 0/8% sucrose layer to yield CCVs. For synaptic-vesicle preparation, synaptosomes isolated from brain homogenate were consecutively purified to give a supernatant of synaptosomal lysate (LS1), pelleted membranes from LS1 (LP2), and the fraction pelleted following collection from a linear sucrose gradient loaded with LP2 (SVP). See Materials and methods for a more detailed explanation of purification procedures. Protein from each step (9 g) was separated by SDS-PAGE and synaptophysin detected by western blotting. neurotransmitter, the vesicles must be filled before entering the releasable pool. In this paper, we have demonstrated that refilling can commence at the earliest intermediate of the recycling pathway -the stage at which the recycling vesicle still bears a clathrin coat. It is widely agreed that uncoating must occur before vesicle release; we speculate that recycling vesicles may fill with neurotransmitter before uncoating is complete, and that, as a consequence, quantal release can be ensured. 
Materials and methods

Antibodies
Vesicle preparation
Synaptic vesicles were prepared according to the method of Huttner et al. [5] , and their terminology has been adopted. Briefly, synaptosomes (P2' fraction) were isolated from brain homogenate. Following lysis of the synaptosomes by osmotic shock, a series of differential centrifugation steps were carried out to produce light membrane fractions (first LS1 and then LP2) enriched in synaptic vesicles. The LP2 pellet was then loaded onto a linear sucrose gradient which, after spinning for 5 h at 65 000 g, was harvested as a turbid band in the 0.2-0.4 M sucrose region (SG-V fraction). The SG-V fraction was diluted in an equal volume of ice-cold distilled water to reduce the sucrose concentration to approximately 0.2 M, and then spun at 185 000 g for 2 h at 4°C (TFT 55.38 rotor; Kontron Instruments). The final synaptic-vesicle pellet (SVP) was resuspended in buffer S (0.32 M sucrose, 10 mM EGTA, 4 mM HEPES-NaOH, pH 7.3) to a final concentration of 2 mg ml -1 , snap frozen and stored at -70°C.
CCVs were prepared from whole rat brain homogenate or isolated rat synaptosomes as described [2] . Briefly, for whole brain isolated CCVs (WB CCVs), a light membrane fraction (LM) was produced from brain homogenate by differential centrifugation steps. The light membranes were subfractionated using a Ficoll gradient to produce a supernatant (PFS). Following further differential centrifugation steps to remove substantial smooth membrane contamination, a supernatant fraction (EF) enriched in CCVs was produced. EF was layered onto D 2 O containing 8% sucrose to yield a pellet of highly purified CCVs following centrifugation. For isolation of CCVs from nerve terminals (NT CCVs), the procedure was essentially the same. Synaptosomes were isolated, washed to remove contaminating smooth membrane, and ruptured using osmotic shock. The lysate was adjusted to iso-osmolarity, and
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Figure 3
Mean glutamate uptake in fractions of CCVs and synaptic vesicles. Normalized to synaptophysin content, the levels of uptake are comparable for whole brain derived CCVs (WB CCV), nerve terminal derived CCVs (NT CCV), and a synaptic-vesicle fraction (SVP). Treatment with 125 nM concanamycin inhibited glutamate uptake to the control levels seen in the absence of ATP and chloride. For each assay, either 100 g WB CCV, 20 g NT CCV or 10 g SVP were used; quantitative analysis indicated that 65 g WB CCV, 30 g NT CCV and 10 g SVP all contained equivalent amounts of synaptophysin (see Fig. 1b ). All incubations were carried out at 30°C for 4 min in the presence of 0.75% ethanol (see Materials and methods). then taken through the same steps as for the brain homogenate in the WB CCV procedure.
The final WB CCV and NT CCV pellets were resuspended in buffer A (0.1 M MES-NaOH, pH 6.5, 1 mM EGTA, 0.5 mM MgCl 2 ) to a final concentration of 3 mg ml -1 (WB CCVs) and 1 mg ml -1 (NT CCVs), snap frozen and stored at -70°C.
Glutamate uptake assay
The glutamate uptake assay of Naito and Ueda [20] was used. For each assay, either 100 g WB CCVs, 20 g NT CCVs, or 10 g SVPs, and 2 Ci L-2,3-[ 3 H]glutamate (TRK-445 20-40 Ci mol -1 , Amersham) were used. For concanamycin studies, concanamycin diluted in ethanol was added to a final concentration of 125 nM, the final ethanol concentration in all incubation mixtures was 0.75%. Vesicles were equilibrated at 30°C for 5 min before uptake was initiated by the addition of glutamate (50 M), with or without 2 mM ATP and 4 mM KCl. Glutamate uptake was continued for 4 min at 30°C before it was abolished by the addition of 2 ml ice-cold 0.15 M KCl; the samples were then vacuum filtered through 25 mm, 0.45 m Millipore filters (Whatman, type HA). Following extensive washing the radioactivity remaining on the filters was counted.
